
Patient samples are a cornerstone of Lyme disease research. They:
A well-curated biorepository ensures researchers have access to consistent, high-quality samples from patients at different stages of disease.
One of the greatest barriers to progress in Lyme and other tick-borne disease research is the limited availability of well-characterized patient samples, especially those paired with detailed clinical data. Without this foundation, advancing diagnostics and treatments is nearly impossible.
GLA recognized this unmet need early and has led efforts to build the infrastructure to close this gap.
A Lyme disease biobank is more than a collection of samples. It’s a collaborative hub that:
2023 © Copyright Global Lyme Alliance. All rights reserved.
Disclaimer: The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. Global Lyme Alliance, Inc. makes no warranties of any kind regarding this Website, including as to the accuracy, completeness, currency or reliability of any information contained herein, and all such warranties are expressly disclaimed.